Intesa Sanpaolo presents Industrial Districts Report. Gros-Pietro, excellent rebound from Covid
19 juil. 2023 05h19 HE | Intesa Sanpaolo
MILAN, Italy, July 19, 2023 (GLOBE NEWSWIRE) -- Focus on the rebound of businesses after the pandemic in Intesa Sanpaolo's "Economy and Finance of Industrial Districts 2022" Report, now in its 15th...
johnson fistel.jpg
Danaher (DHR) Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors with Losses Exceeding $100,000 to Seek Representation
18 juil. 2023 12h10 HE | Johnson Fistel, LLP
SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, a shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of Danaher Corporation ("Danaher" or...
Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB
28 juin 2023 09h00 HE | Sirona Biochem Corp.
VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- June 28, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is excited to announce the development of a...
InflaRx on large white.jpg
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
28 juin 2023 07h30 HE | InflaRx N.V.
Camilla Chong, M.D., joins the team with 25 years of experience in the global pharmaceutical industry in drug developmentDr. Chong to lead clinical development of InflaRx’s portfolio of C5a/C5aR...
InflaRx on large white.jpg
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
21 juin 2023 07h00 HE | InflaRx N.V.
Gohibic is now commercially available for hospitals in the U.S.Gohibic can be used under an Emergency Use Authorization (EUA) granted by the FDA for treatment of certain critically ill COVID-19...
Hospitals Improperly Refuse to Allow Ivermectin for COVID and Yet Defend Right to Do So, according to Journal of American Physicians and Surgeons
19 juin 2023 14h07 HE | Association of American Physicians and Surgeons
TUCSON, Ariz., June 19, 2023 (GLOBE NEWSWIRE) -- A number of hospitals have been sued for refusing to allow patients dying of COVID to receive treatment with ivermectin. If the hospital lost, it...
THE WALT DISNEY COMPANY INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Disney Investors of a Class Action Lawsuit and Upcoming Deadline
24 mai 2023 13h01 HE | Kaplan Fox & Kilsheimer LLP
NEW YORK, May 24, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of The Walt Disney Company (“Disney” or the...
HOK Signals its Investment in Downtown Los Angeles with Studio Relocation to the Arts District
27 avr. 2023 11h00 HE | HOK
LOS ANGELES, April 27, 2023 (GLOBE NEWSWIRE) -- In a move that reflects its bold, creative and forward-thinking culture, HOK’s Los Angeles studio has chosen to relocate its award-winning Southern...
InflaRx on large white.jpg
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
04 avr. 2023 14h55 HE | InflaRx N.V.
Vilobelimab is the first authorized drug to control complement factor C5a, a protein that plays an important and often harmful role in the body's immune responseFDA granted EUA based on Phase III...
Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
28 mars 2023 08h05 HE | Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...